Skip to main content

Advertisement

Table 1 Characteristics of users and non-users of CAM and prayer-for-health

From: Prayer-for-health and complementary alternative medicine use among Malaysian breast cancer patients during chemotherapy

   Included prayer-for-health Excluded prayer-for-health Prayer-for-health only
Characteristics All participants N = 546 CAM users N = 386 Non-CAM users N = 160 X2 CAM users N = 361 Non-CAM users N = 185 X2 Users N = 159 Non-users N = 387 X2
n (%) n (%) n (%) p-value n (%) n (%) p-value n (%) n (%)  
Age Mean ± SD 51.6 ± 9.2           
 30–39 58 (10.6) 45 (11.7) 13 (8.1) 0.52 40 (11.1) 18 (9.7) 0.97 18 (11.3) 40 (10.3) 0.84
 40–49 155 (28.4) 109 (28.2) 46 (28.8)   102 (28.3) 53 (28.6)   43 (27.0) 112 (28.9)  
 50–59 235 (43.0) 167 (43.3) 68 (42.5)   154 (42.7) 81 (43.8)   72 (45.3) 163 (42.1)  
 60 and above 98 (18.0) 65 (16.8) 33 (20.6)   65 (18.0) 33 (17.8)   26 (16.4) 72 (18.6)  
Ethnicity           
 Malay 246 (45.1) 179 (46.4) 67 (41.9) 0.47 164 (45.4) 82 (44.3) 0.18 98 (61.6) 148 (38.2) <.001**
 Chinese 207 (37.9) 141 (36.5) 66 (41.2)   136 (37.7) 71 (38.4)   34 (21.4) 173 (44.7)  
 Indian 80 (14.7) 54 (14.0) 26 (16.2)   49 (13.6) 31 (16.8)   24 (15.1) 56 (14.5)  
 Others 13 (2.4) 12 (3.1) 1 (0.6)   12 (3.3) 1 (0.5)   3 (1.9) 10 (2.6)  
Education level           
 Primary/lower 119 (21.8) 68 (17.6) 51 (31.9) <.001** 65 (18.0) 54 (29.2) <.001* 27 (17.0) 92 (23.8) 0.19
 Secondary 291 (53.3) 203 (52.6) 88 (55.0)   188 (52.1) 103 (55.7)   88 (55.3) 203 (52.5)  
 Tertiary 136 (24.9) 115 (29.8) 21 (13.1)   108 (29.9) 28 (15.1)   44 (27.7) 92 (23.8)  
Marital status           
 Single 60 (11.0) 44 (11.4) 16 (10.0) 0.63 43 (11.9) 17 (9.2) 0.34 22 (13.8) 38 (9.8) 0.17
 Ever married 486 (89.0) 342 (88.6) 144 (90.0)   318 (88.1) 168 (90.8)   137 (86.2) 349 (90.2)  
Household income/month           
 ≤RM 3000(≈944 USD) 393 (72.0) 253 (65.5) 140 (87.5) <.001** 239 (66.2) 151 (83.2) <.001* 96 (60.4) 297 (76.7) <.001**
 >RM 3000(≈944 USD) 153 (28.0) 133 (34.5) 20 (12.5)   122 (33.8) 31 (16.8)   63 (39.6) 90 (23.3)  
Staging of disease           
 Early 338 (61.9) 228 (59.1) 110 (68.8) 0.03* 212 (58.7) 126 (68.1) 0.03* 82 (51.6) 256 (66.1) <.001**
 Advanced 208 (38.1) 158 (40.9) 50 (31.2)   149 (41.3) 59 (31.9)   77 (48.4) 131 (33.9)  
Menopausal status           
 Pre menopause 249 (45.6) 184 (47.7) 65 (40.6|) 0.13 169 (46.8) 80 (43.2) 0.43 81 (50.9) 168 (43.4) 0.11
 Post menopause 297 (54.4) 202(52.3) 95 (59.4)   192 (53.2) 105 (56.8)   78 (49.1) 219 (56.6)  
Chemotherapy regimen           
 Docetaxel 120 (22.0) 91 (23.6) 29 (18.1) 0.16 86 (23.8) 34 (18.4) 0.15 37 (23.3) 83 (21.4) 0.64
 FEC/FAC/CMF/AC 426 (78.0) 295 (76.4) 131 (81.9)   275 (76.2) 151 (81.6)   122 (76.7) 304 (78.6)  
Chemotherapy cycle           
 2, 3 and 4 368 (67.4) 258 (66.8) 110 (68.8) 0.66 238 (65.9) 130 (70.3) 0.31 109 (68.6) 259 (66.9) 0.71
 5 and 6 178 (32.6) 128 (33.2) 50 (31.2)   123 (34.1) 55 (29.7)   50 (31.4) 128 (33.1)  
Chemotherapy adherence           
 Postponed 45 (8.2) 41 (10.6) 4 (2.5) <.001** 39 (10.8) 6 (3.2) <.001** 10 (6.3) 35 (9.0) 0.28
 On schedule 501 (91.8) 345 (89.4) 156 (97.5)   322 (89.2) 179 (96.8)   149 (93.7) 352 (91.0)  
  1. **p < 0.001.
  2. *p < 0.05.